Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled study

Schmidt, O ; Ohta, K ; Ichinose, M ; Tohda, Y ; Engel, M ; Moroni-Zentgraf, P ; Kunimitsu, S ; Sakamoto, W ; Adachi, M

Pneumologie, 2015, Vol.69 (S 01) [Periódico revisado por pares]

Texto completo disponível